CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit

NCT ID: NCT06260345

Last Updated: 2024-02-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2030-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Severe bacterial infections are a worldwide scourge. However, the epidemiology of this type of infection varies over time. It is therefore essential to monitor them in order to prevent them more effectively. At this time, in France, no monitoring exists for this kind of infections.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main aim of this study is to assess the number of cases and describe the clinical, biological and microbiological characteristics of these cases of severe communautary invasive bacterial infections in children hospitalized in pediatric intensive care units. In addition, the management of these hospitalized children will be described.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hospitalized Children Severe Infection Invasive Bacterial Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \<18 years (only hospitalized children)
* Severe communautary bacterial infection defined by hospitalization in a pediatric intensive care unit (documentation of infection by identification of the bacteria in a sterile environment).

Exclusion Criteria

* Refusal by one of the parents or by Child in understanding age
* Nosocomial infection
Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GFRUP (Groupe Francophone de Réanimation et d'Urgences Pédiatrique)

UNKNOWN

Sponsor Role collaborator

Groupe de Pathologies Infectieuses Pédiatriques (GPIP)

OTHER

Sponsor Role collaborator

Centre National de Référence des Streptocoques

UNKNOWN

Sponsor Role collaborator

Centre National de Référence des Pneumocoques

UNKNOWN

Sponsor Role collaborator

Centre National de Référence des Méningocoques et Haemophilus influenzae

UNKNOWN

Sponsor Role collaborator

Centre National de Référence des staphylocoques

UNKNOWN

Sponsor Role collaborator

Centre National de Référence des E. Coli

UNKNOWN

Sponsor Role collaborator

Association Clinique Thérapeutique Infantile du val de Marne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Levy

Role: PRINCIPAL_INVESTIGATOR

CHU Robert Debré, Paris

Corinne Levy

Role: STUDY_DIRECTOR

Association Clinique Thérapeutique Infantile du val de Marne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Association Clinique Thérapeutique Infantile du val de Marne

Créteil, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Corinne Levy

Role: CONTACT

1 48 85 04 04 ext. +33

stéphane Béchet

Role: CONTACT

1 48 85 04 04 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Corinne Levy, MD

Role: primary

1 48 85 04 04 ext. +33

Stéphane Béchet, MsC

Role: backup

1 48 85 04 04 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CAPRICE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.